hydroxychloroquine

The NIH said that while the anti-malarial drug did not cause harm to patients in the study, testing showed little evidence that it would benefit patients hospitalized with COVID-19.

Emergency use authorization makes it easier for doctors to use a drug in a manner not specifically approved by the Food and Drug Administration. The FDA granted these drugs this status in March.

A study of more than 800 health workers, first responders and others finds that taking hydroxychloroquine to prevent COVID-19 is no better than a placebo in preventing the illness.

The WHO cited a scientific study published last week suggesting that proposed COVID-19 drug hydroxychloroqine may do more harm than good in halting its study to review data.

Richard Bright says he was removed from his post because of his "insistence" that the government spend funds on "safe and scientifically vetted solutions" to address the coronavirus.

The group of experts, assembled under the agency run by Dr. Anthony Fauci, warns that using a combination of hydroxychloroquine and azithromycin could result in potential toxicities.

While there is anecdotal evidence hydroxychloroquine has helped manage some patients’ symptoms, there is no data that proves it is effective in treating or preventing COVID-19. But absent that kind of data, there has been confusion around how exactly to use the drug to treat patients sick with the virus — and whether it is effective.